State of Alaska Department of Revenue increased its position in HealthEquity, Inc. (NASDAQ:HQY) by 80.4% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 8,748 shares of the company’s stock after buying an additional 3,898 shares during the period. State of Alaska Department of Revenue’s holdings in HealthEquity were worth $435,000 at the end of the most recent quarter.
Other hedge funds also recently made changes to their positions in the company. Russell Investments Group Ltd. bought a new stake in shares of HealthEquity during the fourth quarter worth $848,000. State Board of Administration of Florida Retirement System boosted its stake in HealthEquity by 2.8% in the fourth quarter. State Board of Administration of Florida Retirement System now owns 22,039 shares of the company’s stock valued at $893,000 after buying an additional 590 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in HealthEquity by 18.9% in the fourth quarter. Dimensional Fund Advisors LP now owns 272,959 shares of the company’s stock valued at $11,061,000 after buying an additional 43,403 shares in the last quarter. Guggenheim Capital LLC acquired a new stake in HealthEquity during the fourth quarter valued at approximately $285,000. Finally, AQR Capital Management LLC acquired a new stake in HealthEquity during the fourth quarter valued at approximately $293,000. Institutional investors and hedge funds own 90.54% of the company’s stock.
Shares of HealthEquity, Inc. (HQY) traded down 4.54% during trading on Friday, reaching $42.08. The company’s stock had a trading volume of 1,305,719 shares. HealthEquity, Inc. has a 12 month low of $28.39 and a 12 month high of $54.95. The company’s 50-day moving average is $47.91 and its 200-day moving average is $46.04. The company has a market capitalization of $2.52 billion, a P/E ratio of 79.10 and a beta of 1.73.
HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Tuesday, June 6th. The company reported $0.19 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.03. HealthEquity had a net margin of 17.04% and a return on equity of 11.61%. The firm had revenue of $55.40 million during the quarter, compared to analysts’ expectations of $54.77 million. During the same quarter in the previous year, the company posted $0.15 EPS. HealthEquity’s revenue was up 25.9% on a year-over-year basis. On average, analysts forecast that HealthEquity, Inc. will post $0.58 EPS for the current fiscal year.
HQY has been the topic of several analyst reports. Chardan Capital raised their target price on HealthEquity from $53.00 to $57.00 and gave the company a “buy” rating in a research report on Wednesday, June 7th. Cantor Fitzgerald raised their target price on HealthEquity from $50.00 to $55.00 and gave the company an “overweight” rating in a research report on Wednesday, June 7th. Oppenheimer Holdings, Inc. restated an “outperform” rating and issued a $61.00 target price (up from $57.00) on shares of HealthEquity in a research report on Monday, June 12th. Zacks Investment Research upgraded HealthEquity from a “hold” rating to a “buy” rating and set a $54.00 target price on the stock in a research report on Wednesday, July 12th. Finally, BidaskClub cut HealthEquity from a “buy” rating to a “hold” rating in a research report on Monday, July 24th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $50.22.
In other HealthEquity news, VP Ashley Dreier sold 10,000 shares of the company’s stock in a transaction on Monday, June 5th. The shares were sold at an average price of $47.81, for a total transaction of $478,100.00. Following the completion of the sale, the vice president now owns 15,652 shares in the company, valued at approximately $748,322.12. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Frank Medici sold 210,906 shares of the company’s stock in a transaction on Wednesday, June 14th. The shares were sold at an average price of $52.03, for a total transaction of $10,973,439.18. Following the sale, the director now owns 6,381 shares of the company’s stock, valued at approximately $332,003.43. The disclosure for this sale can be found here. Insiders sold a total of 2,449,321 shares of company stock valued at $125,721,793 in the last 90 days. 29.00% of the stock is currently owned by corporate insiders.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.